0001237899-19-000038.txt : 20191213 0001237899-19-000038.hdr.sgml : 20191213 20191213180312 ACCESSION NUMBER: 0001237899-19-000038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191211 FILED AS OF DATE: 20191213 DATE AS OF CHANGE: 20191213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenimore Christopher R. CENTRAL INDEX KEY: 0001697422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 191285544 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-12-11 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001697422 Fenimore Christopher R. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller Common Stock 2019-12-11 4 A 0 1020 0.0 A 9697 D Common Stock 2019-12-11 4 A 0 2500 0.0 A 12197 D Common Stock 2019-12-12 4 M 0 3100 52.03 A 15297 D Common Stock 2019-12-12 4 F 0 1418 377.16 D 13879 D Common Stock 2019-12-13 4 S 0 191 374.82 D 13688 D Common Stock 2019-12-13 4 S 0 624 375.58 D 13064 D Common Stock 2019-12-13 4 S 0 470 376.27 D 12594 D Common Stock 2019-12-13 4 S 0 346 377.38 D 12248 D Common Stock 2019-12-13 4 S 0 51 378.27 D 12197 D Common Stock 1401 I By 401(k) Plan Common Stock 1897 I By Trust Common Stock 509 I by 2017 GRAT Common Stock 2284 I by 2018 GRAT Non-Qualified Stock Option (right to buy) 52.03 2019-12-12 4 M 0 3100 0.0 D 2021-12-16 Common Stock 3100 7226 D Non-Qualified Stock Option (right to buy) 372.46 2019-12-11 4 A 0 6120 0.0 A 2029-12-11 Common Stock 6120 6120 D Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023. Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 11, 2023. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 191 shares of Company stock on December 13, 2019 at prices ranging from $374.65 to $374.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price. Represents volume-weighted average price of sales of 624 shares of Company stock on December 13, 2019 at prices ranging from $375.05 to $375.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price. Represents volume-weighted average price of sales of 470 shares of Company stock on December 13, 2019 at prices ranging from $376.02 to $376.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price. Represents volume-weighted average price of sales of 346 shares of Company stock on December 13, 2019 at prices ranging from $377.09 to $377.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Christopher R. Fenimore 2019-12-13